204 related articles for article (PubMed ID: 19147687)
1. The National Cancer Institute and its Director: worthy of our full support.
Chabner BA
Oncologist; 2009 Feb; 14(2):108-9. PubMed ID: 19147687
[No Abstract] [Full Text] [Related]
2. Bottom-line reality tempers cancer researchers' excitement.
Benowitz S
J Natl Cancer Inst; 2009 Sep; 101(17):1166-9. PubMed ID: 19679851
[No Abstract] [Full Text] [Related]
3. Awards bridge 'valley of death'.
Dorey E
Nat Biotechnol; 2009 Aug; 27(8):678. PubMed ID: 19668154
[No Abstract] [Full Text] [Related]
4. U.S. election. McCain, Obama present their wars on cancer.
Couzin J
Science; 2008 Sep; 321(5895):1432. PubMed ID: 18787141
[No Abstract] [Full Text] [Related]
5. A cure for cancer research.
Nat Med; 2010 Aug; 16(8):829. PubMed ID: 20689526
[No Abstract] [Full Text] [Related]
6. StatBite: Stimulus funding: where does the NCI propose to invest?
J Natl Cancer Inst; 2009 Sep; 101(17):1169. PubMed ID: 19679852
[No Abstract] [Full Text] [Related]
7. National Cancer Institute helps businesses cross 'the valley of death'.
Nair P
Nat Med; 2008 Aug; 14(8):795. PubMed ID: 18685581
[No Abstract] [Full Text] [Related]
8. Stone Soup: commentary on "Five strategies for accelerating the war on cancer in an era of budget deficits".
Young RC
Oncologist; 2009 Feb; 14(2):117-8. PubMed ID: 19211619
[No Abstract] [Full Text] [Related]
9. Researchers left to guess at outcomes of most cancer clinical trials.
Twombly R
J Natl Cancer Inst; 2009 Jan; 101(2):72-4. PubMed ID: 19141774
[No Abstract] [Full Text] [Related]
10. Early warning: an ailing canary in the mine.
Dilts DM
J Clin Oncol; 2010 Aug; 28(24):3799-800. PubMed ID: 20644096
[No Abstract] [Full Text] [Related]
11. Leaders worry that U.S. is losing edge on cancer clinical trials.
Twombly R
J Natl Cancer Inst; 2008 Sep; 100(17):1196-9. PubMed ID: 18728275
[No Abstract] [Full Text] [Related]
12. From the editor. Translational Research Working Group roadmaps for cancer research.
Bates SE
Clin Cancer Res; 2008 Sep; 14(18):5663. PubMed ID: 18794073
[No Abstract] [Full Text] [Related]
13. Central institutional review board-facilitated review metrics omit critical components.
Katz MS; Smith ML
J Clin Oncol; 2010 Feb; 28(6):e105; author reply e106. PubMed ID: 20100953
[No Abstract] [Full Text] [Related]
14. Research leaders praise funding increases.
Printz C
Cancer; 2009 Jun; 115(11):2377-8. PubMed ID: 19455712
[No Abstract] [Full Text] [Related]
15. United States military contributions to the National Cancer Institute.
Sarvis JA; Thompson IM
Urol Oncol; 2009; 27(5):558-61. PubMed ID: 19720303
[TBL] [Abstract][Full Text] [Related]
16. Cancer research: evaluating the sequester's impact.
Schmidt C
J Natl Cancer Inst; 2013 Aug; 105(16):1160-1. PubMed ID: 23904503
[No Abstract] [Full Text] [Related]
17. How we really help Ted.
Alter J
Newsweek; 2008 Jun; 151(22):31. PubMed ID: 18850682
[No Abstract] [Full Text] [Related]
18. Five strategies for accelerating the war on cancer in an era of budget deficits.
Doroshow JH; Croyle RT; Niederhuber JE
Oncologist; 2009 Feb; 14(2):110-6. PubMed ID: 19147688
[TBL] [Abstract][Full Text] [Related]
19. Improving cancer research. Leaders cite collaboration and increased areas of study as ways to fight the disease.
Printz C
Cancer; 2013 May; 119(10):1765-6. PubMed ID: 23649487
[No Abstract] [Full Text] [Related]
20. Doug Lowy becomes acting director of National Cancer Institute.
Schmidt C
J Natl Cancer Inst; 2015 May; 107(5):. PubMed ID: 25957443
[No Abstract] [Full Text] [Related]
[Next] [New Search]
